Table 1.

. Patient characteristics

UPN1	Sex (M/F)2	Age3	FAB4	Material5	Blasts (%)6	Cytogenetics
1	M	49	M0	BM	85	92 XXYY, der (15;15)(q10;q10)
2	M	55	M1	BM	86	del (9) (q11;q22)
3	M	76	M1	BM	82	Normal
4	M	72	M1	BM	72	Normal
5	F	61	M1	PBMC	83	del (11) (q13;q25)
6	M	69	M2	BM	45	Normal
7	M	24	M3	BM	86	t(15;17)
8	F	46	M4eo	BM	68	inv (16)
9	F	35	M4eo	PBMC	51	inv (16) del (7) (q22)
10	F	33	M4eo	PBMC	34	Monosomy (7)
11	F	22	M4eo	BM	70	inv (16)
12	F	34	M4eo	BM	31	inv (16)
13	F	69	M5a	BM	84	no metaphases
14	M	37	M5a	BM	95	Normal
15	F	46	M5a	BM	97	t(9;11) (p22;q23)
16	M	38	M5a	BM	84	Normal
17	F	54	M5a	BM	97	Normal
18	F	63	RAEB-t	BM	23	Normal
19	M	77	Unclassified	BM	95	Not tested

¹Unique patient number.

² M male, F female.

³Age at diagnosis (years).

⁴French-American-British classification.

⁵ BM bone marrow, PBMC peripheral blood mononuclear cells.

⁶Percentages of blasts were scored in May-Grünwald-Giemsa stained bone marrow smears or PBMC before gradient cell separation.